Navigation Links
Satyam Partners with Oracle to Provide Clinical Development Applications

-- Global Certified Advantage Partnership streamlines management of patient

data collected during clinical trials

HYDERABAD, India, Sept. 23 /PRNewswire-FirstCall/ -- Satyam Computer Services Ltd. (NYSE: SAY), a leading global consulting and information technology services provider, announced today it is working with Oracle's new Health Sciences Global Business Unit to provide leading clinical development applications. The solution, which Satyam is offering under the umbrella of "Clinical xPress," will help pharmaceutical, biotech and contract research organizations (CROs) more effectively address their most pressing business challenges, such as cost containment, safety management and accelerated time to market.

Satyam will be among the first to offer Oracle's suite of clinical development and safety applications, including Oracle(R) Remote Data Capture, Oracle(R) Clinical, Oracle(R) Adverse Event Reporting System, Oracle Thesaurus Management System and Oracle(R) Life Sciences Data Hub. It is the health sciences sector's most comprehensive suite of applications for clinical development and safety. Clinical xPress will be offered to clients on a subscription-based pricing model, enabling Satyam to provide its customers with end-to-end solutions for clinical development in ways that are affordable and flexible, and which are tailored to each client's unique budget.

"Satyam has been investing strategically to build Oracle-based life sciences solutions," said Kishore Rachapudi, Global Head, Satyam Life Sciences. "We are committed to providing modular, flexible services via Clinical xPress. This unique relationship allows our global customers to select services such as IT, Software as a Service, BPO and clinical data management."

Rachapudi also noted that the relationship demonstrates Satyam's commitment to business outcomes, and to driving its clients' transformation programs. "With Clinical xPress," he said, "we can enable pharmaceutical, biotech, CROs and medical device companies to optimize costs and accelerate drug development."

"We believe that expanding our relationship with Satyam and leveraging its life sciences sector expertise will help support our mission to accelerate insights for better health," said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences Global Business Unit. "Through closer alignment, Oracle and Satyam will be better positioned to deliver value to customers and help them create best-in-class systems to manage the large volume of patient data collected during clinical trials."

About Satyam

Satyam (NYSE: SAY), a leading global business and information technology services company, delivers consulting, systems integration, and outsourcing solutions to clients in 20* industries and 66* countries.

Satyam leverages deep industry and functional expertise, leading technology practices, and an advanced, global delivery model to help clients transform their highest-value business processes and improve their business performance. The company's 51,643* professionals excel in engineering and product development, supply chain management, client relationship management, business process quality, business intelligence, enterprise integration, and infrastructure management, among other key capabilities.

Satyam development and delivery centers in the US, Canada, Brazil, the UK, Hungary, Egypt, UAE, India, China, Malaysia, Singapore, and Australia serve 670* clients, including more than one third of the Fortune 500. For more information, see

*As of June 30, 2008

About the Oracle PartnerNetwork

Oracle PartnerNetwork is a global business network of more than 19,500 companies who deliver innovative software solutions based on Oracle software. Through access to Oracle's premier products, education, technical services, marketing and sales support, the Oracle PartnerNetwork program provides partners with the resources they need to be successful in today's global economy. Oracle partners are able to offer their customers leading-edge solutions backed by Oracle's position as the world's largest enterprise software company. Partners who are able to demonstrate superior product knowledge, technical expertise and a commitment to doing business with Oracle qualified for the Certified Partner levels.

Satyam Contacts

For clarifications, write to us at:

Or contact our PR representatives:

India Deepa Jayaraman


Ajith Henry


US James Swords


Europe Sandeep Thawani


Asia-Pacific Dan Bleakman


Reshma Wad Jain


Safe Harbor

This press release contains forward-looking statements within the meaning of section 27A of Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements contained herein are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Satyam undertakes no duty to update any forward-looking statements. For a discussion of the risks associated with our business, please see the discussions under the heading "Risk Factors" in our report on Form 6-K concerning the quarter ended June 30, 2008, furnished to the Securities and Exchange Commission on July 25, 2008, and the other reports filed with the Securities and Exchange Commission from time to time. These filings are available at


Oracle is a registered trademark of Oracle Corporation and/or its affiliates.

SOURCE Satyam Computer Services Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Satyam Forms Partnership with Sciformix to Provide Comprehensive Drug Safety Management
2. alli(TM) Partners with Breast Cancer Network of Strength(TM) to Support Women Challenged by Breast Cancer, Weight Loss or Both
3. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
4. Transgenomic Announces Partnership With Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options
5. Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
6. Oramed Pharmaceuticals Partners With ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule, ORMD 0801
7. NIST and partners identify tiny gold clusters as top-notch catalysts
8. Medarex to Present at the Thomas Weisel Partners Healthcare Conference
9. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
10. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
11. Gen-Probe to Webcast Presentation at the Thomas Weisel Partners Healthcare Conference 2008
Post Your Comments:
(Date:11/27/2015)... 2015 --> ... companion diagnostics is one of the major ... pharmaceutical companies and diagnostic manufacturers working together ... . --> ... global cancer biomarkers market spread across 89 ...
(Date:11/25/2015)... 2015 --> ... - 2020 report analyzes that automating biobanking workflow ... in long-term samples, minimizing manual errors, improving the ... manual errors such as mislabeling or inaccurate sample ... plays a vital role in blood fractionation, DNA ...
(Date:11/25/2015)... , November 25, 2015 ... cat and human plaque and pave the way for more ... problems in cats     --> ... most commonly diagnosed health problems in cats, yet relatively little ... now. Two collaborative studies have been conducted by researchers from ...
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
Breaking Biology Technology:
(Date:11/4/2015)... , November 4, 2015 ... new market report published by Transparency Market Research "Home Security ... Trends and Forecast 2015 - 2022", the global home security ... 30.3 bn by 2022. The market is estimated to ... period from 2015 to 2022. Rising security needs among ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
(Date:10/27/2015)... Germany , October 27, 2015 ... SMI,s Automated Semantic Gaze Mapping technology (ASGM) automatically maps ... SMI,s Eye Tracking Glasses , so that they ... BeGaze. --> Munich, Germany , ... (ASGM) automatically maps data from mobile eye tracking videos ...
Breaking Biology News(10 mins):